Table 1 Detailed list of patients
From: Characteristics of cases needing advanced treatment for intractable Posner–Schlossman syndrome
Case | Gender | Affected eye | Reduction rate (%) | Highest IOP (mmHg) | Pre Treat VA (log MAR) | Final MD (dB) | PCR | Ope |
|---|---|---|---|---|---|---|---|---|
1 | M | L | -1.5 | 31 | -0.1 | NP | − | − |
2 | F | R | 4.4 | 35 | 0.1 | NP | − | − |
3 | F | R | 7 | 14 | -0.1 | −0.32 | − | − |
4 | F | R | 9.7 | 27 | 0.2 | NP | − | − |
5 | M | L | 15.6 | 19 | 1 | GP | − | − |
6 | M | R | 21.8 | 23 | −0.2 | -8.33 | CMV | − |
7 | F | R | 43.8 | 46 | 0.1 | −0.4 | − | − |
8 | F | R | 4.9 | 42 | −0.1 | −1.37 | − | − |
9 | M | R | 72.7 | 26 | 0 | −0.28 | − | − |
10 | M | R | 8.3 | 43 | −0.2 | −1.43 | − | − |
11 | F | L | 2.2 | 49 | −0.1 | −0.46 | − | − |
12 | F | L | 17.6 | 26 | −0.2 | 0.8 | − | − |
13 | M | R | 9.1 | 68 | 0.4 | −28.38 | − | + |
14 | F | L | 23.3 | 68 | −0.2 | -6.45 | CMV | + |
15 | M | R | 23.9 | 68 | −0.1 | −4.38 | − | + |
16 | F | R | 25 | 68 | 0.3 | −2.2 | − | + |
17 | M | R | 31.9 | 68 | 0 | −4.76 | − | + |
18 | M | R | 31.9 | 68 | 0.1 | −7.4 | − | + |
19 | M | L | 31.6 | 68 | -0.1 | GP | − | + |
20 | F | L | 40.8 | 68 | -0.1 | 1.67 | Parvo B19 | + |
21 | F | L | 59.6 | 68 | 0 | −5.25 | − | + |
22 | F | L | 74.6 | 68 | 0.5 | −6.31 | − | + |
23 | F | R | 7.8 | 68 | 0 | −16.9 | − | + |
24 | M | R | 32.6 | 68 | 0 | -6.17 | CMV | + |
25 | M | R | 4.4 | 68 | −0.2 | −26.27 | − | + |
26 | F | R | 28 | 68 | 0 | -19.82 | CMV | + |
27 | M | R | 8.8 | 68 | 0.5 | -30.85 | CMV | + |
28 | M | L | 45.6 | 42 | −0.2 | −27.65 | − | + |
29 | F | L | 64.7 | 42 | −0.1 | -6.57 | CMV | + |
30 | M | L | 9.7 | 34 | 0.2 | -24.98 | CMV | + |
31 | M | R | 25.3 | 44 | −0.2 | −14.16 | − | + |
32 | M | R | 62.3 | 46 | 0 | 17.34 | − | + |
33 | M | L | 26 | 43 | 0.4 | −22.478 | − | + |